"The main point is that their 100% claims were on late stage cancer patients so they have got a lot more testing to do and HTX are further ahead with better accuracy than their current expected."TDA post later date.
HTX Price at posting:
7.3¢ Sentiment: LT Buy Disclosure: Held
